Pruthi Deepak K, Wang Hanzhang, Satsangi Arpan, Cajipe Miguel, Iffrig Kevan, Haidar Georges M, Hicks Taylor, Sako Edward Y, Liss Michael A, Chowdhury Wasim H, Rodriguez Ronald, Kaushik Dharam
Department of Urology.
Department of Vascular Surgery.
Can Urol Assoc J. 2018 Sep;12(9):E391-E397. doi: 10.5489/cuaj.5013.
Radical nephrectomy (RN) with venous tumour thrombectomy (VTT) carries a significant morbidity and mortality risk. Examination of a contemporary single-institution series permits the development of a management algorithm and an audit its results. We report outcomes following the use of intraoperative colour Doppler ultrasound and our surgical pathway.
We retrospectively reviewed the records of all patients who underwent RN with VTT for kidney cancer between January 1, 2013 and October 1, 2016. Surgical complications, postoperative complications (Clavien-Dindo classification ≥3), 90-day readmission rates, and outcomes are reported. Multivariate linear regression, logistic regression, and Cox proportional hazard modelling were used to identify associations.
Fifty-eight patients underwent RN with VTT. Of these, 26 (45%) patients had Mayo Clinic level III or IV thrombus and nineteen required venovenous/cardiopulmonary bypass. Three patients required patch grafting. The median length of hospital stay was eight days and there were 20 major complications. The 30-day readmission rate was 21% and the 90-day mortality rate was 8.9%. In multivariate analysis, low serum albumin and age-adjusted Charlson comorbidity score predicted length of stay. Increased intraoperative blood loss was significantly associated with increasing body mass index, serum creatinine, tumour thrombus level, and a history of significant weight loss >9.1kg. Low serum hematocrit predicted 90-day mortality.
Intraoperative colour Doppler ultrasound is a useful tool and can facilitate caval preservation. Caval grafting can be avoided in most cases. Venovenous bypass can be avoided in many level III cases. Early therapeutic anticoagulation should be instituted with caution.
根治性肾切除术(RN)联合静脉肿瘤血栓切除术(VTT)具有显著的发病和死亡风险。对当代单机构系列病例的研究有助于制定管理算法并评估其结果。我们报告了术中使用彩色多普勒超声后的结果以及我们的手术路径。
我们回顾性分析了2013年1月1日至2016年10月1日期间所有接受RN联合VTT治疗肾癌患者的记录。报告了手术并发症、术后并发症(Clavien-Dindo分类≥3)、90天再入院率和治疗结果。采用多变量线性回归、逻辑回归和Cox比例风险模型来确定相关性。
58例患者接受了RN联合VTT治疗。其中,26例(45%)患者有梅奥诊所III级或IV级血栓,19例需要静脉-静脉/心肺转流。3例患者需要补片移植。中位住院时间为8天,有20例主要并发症。30天再入院率为21%,90天死亡率为8.9%。在多变量分析中,低血清白蛋白和年龄校正的Charlson合并症评分可预测住院时间。术中失血增加与体重指数增加、血清肌酐、肿瘤血栓水平以及体重显著减轻>9.1kg的病史显著相关。低血清血细胞比容可预测90天死亡率。
术中彩色多普勒超声是一种有用的工具,可有助于保留腔静脉。在大多数情况下可避免腔静脉移植。在许多III级病例中可避免静脉-静脉转流。早期治疗性抗凝应谨慎实施。